With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
LIN trades against a final fair-value range of $208.99-$355.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A rapid normalization of Linde's terminal multipleTerminal multipleThe exit P/E or EV/EBITDA we apply to the final year of an explicit forecast. Anchored to the business's long-run quality and the prevailing risk-free rate. from ~25x to our 15x cyclical baseline, paired with a global industrial recession. High capital intensity limits downside cash flow flexibility, dragging FCFFFree cash flow to firmCash flow available to all capital providers (debt and equity) before financing costs. Discounted at WACC to derive enterprise value. intrinsic valueIntrinsic valueThe discounted present value of all cash a business will produce over its remaining life. The theoretical anchor for fair value, computed in practice as a range across explicit assumptions. down to the $234 level.
Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
Prolonged global manufacturing and metals recession drives base volumes down, completely offsetting the downside protection of take-or-pay minimums.
Accelerated clean energy investments require structurally higher capex without commensurate return on invested capital, impairing FCFF generation.
| Line item | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| Revenue | — | $33.36B | $32.85B-1.5% | $33.01B+0.5% | $33.99B+3.0% | +0.5% |
| Gross profit | — | $13.91B | $15.36B | $15.86B | $16.60B | +4.5% |
| Operating income | — | $6.46B | $8.11B | $8.60B | $9.25B | +9.4% |
| Net income | — | $4.15B | $6.20B+49.4% | $6.57B+6.0% | $6.90B+5.0% | +13.6% |
| EPS (diluted) | $7.33 | $8.23 | $12.59 | $13.62 | $14.61 | +18.8% |
| EBITDA | — | $9.96B | $12.22B | $12.84B | $13.12B | +7.1% |
| R&D | — | $143.0M | $146.0M | $150.0M | $147.0M | +0.7% |
| SG&A | — | $3.11B | $3.30B | $3.34B | $3.43B | +2.5% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Monitor |
| Deterioration versus the report thesis |
| Gross margin compression below 40%, signaling a loss of highly prized localized pricing power. | Monitor | Deterioration versus the report thesis |
| Significant downward revisions or delays in clean energy and hydrogen project backlogs. | Monitor | Deterioration versus the report thesis |
